reviewHeadache The Journal of Head and Face PainApr 14, 2019HYBRID OA

CGRP and the Trigeminal System in Migraine

Eli Lilly (United States) · Syneos Health (United States)

PubMed
Indexed incrossrefpubmed

Abstract

Objective

The goal of this narrative review is to provide an overview of migraine pathophysiology, with an emphasis on the role of calcitonin gene-related peptide (CGRP) within the context of the trigeminovascular system.

Background

Migraine is a prevalent and disabling neurological disease that is characterized in part by intense, throbbing, and unilateral headaches. Despite recent advances in understanding its pathophysiology, migraine still represents an unmet medical need, as it is often underrecognized and undertreated. Although CGRP has been known to play a pivotal role in migraine for the last 2 decades, this has now received more interest spurred by the early clinical successes of drugs that block CGRP signaling in the trigeminovascular system.

Citation impact

486
total citations
FWCI
27.58
Percentile
100%
References
191
Citations per year

Authors

4

Topics & keywords

Keywords
  • Calcitonin gene-related peptide
  • Trigeminal ganglion
  • Migraine
  • Medicine
  • Neuroscience
  • Trigeminal nerve
  • Context (archaeology)
  • Ganglion
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding